Microalbuminuria and pegylated interferon in hepatitis-C patients.
Microalbuminuria and pegylated interferon in hepatitis-C patients.
Saudi J Kidney Dis Transpl. 2015 Nov-Dec;26(6):1183-1189
Authors: Elshahawi Y, Sany D, Abd Elmohsen WA, Tantawi T
Abstract
To determine the relation between hepatitis C virus (HCV) genotype 4 and microalbuminuria in relation to hepatic histology and viremia in the absence of cryoglobulinemia and to examine the effect of treatment on microalbuminuria, we studied 400 HCV genotype-4-infected patients who were tested for microalbuminuria, albumin creatinine ratio (ACR), urea, creatinine and estimated glomerular filtration rate (eGFR). The parameters were measured again in the HCV patients after six months of treatment with pegylated interferon and ribavirin. Microalbuminuria was detected in 56 (14%) HCV-positive patients. There was a highly significant reduction in the microalbuminuria levels among the HCV-positive individuals after six months of therapy (P <0.001). Microalbuminuria was significantly associated with older age [Odds Ratio (OR): 1.1, 95% confidence interval (CI): 1.0-1.2, P = 0.01], elevated creatinine (OR: 0.09, 95% CI: 0.01- 0.7, P = 0.02), high modified Histological Activity Index score (OR: 1.5, 95% CI: 1.1-1.5, P = 0.004) and increased viral load (OR: 2.8, 95% CI: 1.1-6.6, P = 0.01). Sustained virological response (SRV) was achieved in 272 (86%) patients. The individuals with SVR had lower microalbuminuria post-treatment (P = 0.56). We conclude that...
Source: Saudi Journal of Kidney Diseases and Transplantation - Category: Urology & Nephrology Authors: Elshahawi Y, Sany D, Abd Elmohsen WA, Tantawi T Tags: Saudi J Kidney Dis Transpl Source Type: research
More News: Hepatitis | Hepatitis C | Kidney Transplant | Kidney Transplantation | Middle East Health | Transplants | Urology & Nephrology | Virology